All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus–coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13–HEPAVIH Cohort | Zendy

Philippe Sogni | Zendy; Camille Gilbert | Zendy; Karine Lacombe | Zendy; Lionel Piroth | Zendy; Éric Rosenthal | Zendy; Patrick Miailhes | Zendy; Anne Gervais | Zendy; Laure Esterle | Zendy; J. Chas | Zendy; Isabelle PoizotMartin | Zendy; Stéphanie Dominguez | Zendy; Anne Simon | Zendy; Philippe Morlat | Zendy; D. Neau | Zendy; David Zucman | Zendy; Olivier Bouchaud | Zendy; Caroline LascouxCombe | Zendy; Firouzé BaniSadr | Zendy; Laurent Alric | Zendy; Cécile Goujard | Zendy; Daniel Vittecoq | Zendy; Eric Billaud | Zendy; Hugues Aumaître | Zendy; François Boué | Zendy; MarcAntoine Valantin | Zendy; François Dabis | Zendy; Dominique Salmon | Zendy; Linda Wittkop | Zendy

Open Access

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus–coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13–HEPAVIH Cohort

Author(s) -

Philippe Sogni,

Camille Gilbert,

Karine Lacombe,

Lionel Piroth,

Éric Rosenthal,

Patrick Miailhes,

Anne Gervais,

Laure Esterle,

J. Chas,

Isabelle PoizotMartin,

Stéphanie Dominguez,

Anne Simon,

Philippe Morlat,

D. Neau,

David Zucman,

Olivier Bouchaud,

Caroline LascouxCombe,

Firouzé BaniSadr,

Laurent Alric,

Cécile Goujard,

Daniel Vittecoq,

Eric Billaud,

Hugues Aumaître,

François Boué,

MarcAntoine Valantin,

François Dabis,

Dominique Salmon,

Linda Wittkop

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw379

Subject(s) - medicine , simeprevir , sofosbuvir , ledipasvir , regimen , ribavirin , hepatitis c , daclatasvir , hepatitis c virus , cohort , gastroenterology , immunology , virus

Human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients with cirrhosis have long been considered to be difficult to treat, and real-life efficacy and tolerance data with all-oral direct-acting antiviral (DAA) combinations in these patients are scarce.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research